What is the recommended antibiotic treatment for a patient with acute bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Acute Bacterial Sinusitis

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-7 days is the preferred first-line antibiotic for adults with acute bacterial sinusitis, due to the high prevalence (20-30%) of β-lactamase-producing organisms that render plain amoxicillin ineffective. 1

Confirming the Diagnosis Before Prescribing

Before initiating antibiotics, confirm the patient meets one of three diagnostic criteria for bacterial (not viral) sinusitis 2, 3:

  • Persistent symptoms ≥10 days without improvement (nasal discharge, congestion, facial pain/pressure) 2, 3
  • Severe symptoms for ≥3-4 consecutive days: fever ≥39°C with purulent nasal discharge 2, 4
  • "Double sickening": worsening symptoms after initial improvement from a viral upper respiratory infection 2, 3

Most acute rhinosinusitis (98-99.5%) is viral and resolves spontaneously within 7-10 days without antibiotics 2. Do not prescribe antibiotics for symptoms lasting <10 days unless severe symptoms are present 2, 3.

First-Line Treatment Algorithm

For Adults Without Penicillin Allergy

Standard therapy: Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-7 days 1, 3

High-dose therapy (use if recent antibiotic exposure within past month, age >65 years, comorbid conditions, or immunocompromised): Amoxicillin-clavulanate 2000 mg/125 mg twice daily 2, 3

The clavulanate component provides essential coverage against β-lactamase-producing Haemophilus influenzae (20-30% of cases) and Moraxella catarrhalis (12-28% of cases) 1. Plain amoxicillin is no longer appropriate as first-line therapy 1, 3.

For Pediatric Patients

Standard therapy: Amoxicillin 45 mg/kg/day in 2 divided doses for 10-14 days 2, 3

High-dose therapy (for age <2 years, daycare attendance, recent antibiotic use, or high local resistance): Amoxicillin-clavulanate 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 2, 1, 3

Penicillin-Allergic Patients

Non-Severe Allergy (Rash, Delayed Reactions)

Second- or third-generation cephalosporins are safe and effective, as the risk of serious cross-reactivity is negligible 2, 1, 3:

  • Cefuroxime-axetil (second-generation): 250-500 mg twice daily 5, 2
  • Cefpodoxime-proxetil (third-generation): 200-400 mg twice daily 5, 2
  • Cefdinir (third-generation): 300 mg twice daily 2, 1

Third-generation cephalosporins provide superior activity against H. influenzae compared to second-generation agents 2.

Severe Type I Hypersensitivity (Anaphylaxis)

Respiratory fluoroquinolones are the treatment of choice 2, 1, 3:

  • Levofloxacin 500 mg once daily for 10-14 days 2, 1, 6
  • Moxifloxacin 400 mg once daily for 10 days 2, 1

Fluoroquinolones demonstrate 90-92% predicted clinical efficacy and 100% microbiologic eradication of S. pneumoniae, including multi-drug resistant strains 2, 6, 7.

Treatment Failure Protocol

Reassess at 3-5 days (adults) or 72 hours (pediatrics) 2, 1, 3. If no improvement or worsening symptoms:

  1. Switch to high-dose amoxicillin-clavulanate (if not already prescribed): 2000 mg/125 mg twice daily for adults 2, 3

  2. If amoxicillin-clavulanate fails, switch to a respiratory fluoroquinolone 2, 1, 3:

    • Levofloxacin 500-750 mg once daily for 10-14 days 2, 6
    • Moxifloxacin 400 mg once daily for 10 days 2, 1
  3. Consider ceftriaxone for patients unable to tolerate oral medications: 1-2 g IM/IV once daily for 5 days (adults) or 50 mg/kg once daily (pediatrics) 2

Antibiotics to AVOID

Never use these agents as first-line therapy for acute bacterial sinusitis:

  • Azithromycin and macrolides: Resistance rates exceed 20-25% for both S. pneumoniae and H. influenzae 2, 1, 8, 4
  • First-generation cephalosporins (cephalexin): Inadequate coverage against H. influenzae 2
  • Clindamycin monotherapy: No activity against H. influenzae or M. catarrhalis 2
  • Trimethoprim-sulfamethoxazole: Resistance rates of 50% for S. pneumoniae and 27% for H. influenzae 2

Adjunctive Therapies That Improve Outcomes

Intranasal corticosteroids should be added to antibiotic therapy in all patients 2, 1, 3:

  • Mometasone, fluticasone, or budesonide twice daily 2, 3
  • Reduces mucosal inflammation and improves symptom resolution 2, 1

Short-term oral corticosteroids (5 days) may be considered for 2:

  • Patients who fail initial antibiotic treatment 2
  • Marked mucosal edema 2
  • Severe pain (acute hyperalgic sinusitis) 2

Supportive measures 2, 1:

  • Intranasal saline irrigation 2
  • Analgesics (acetaminophen, NSAIDs) 2
  • Adequate hydration 2
  • Warm facial packs 2

Treatment Duration

Adults: 5-7 days for uncomplicated maxillary sinusitis 1, 3. Shorter courses (5-7 days) have comparable efficacy with fewer side effects compared to 10-14 day courses 2, 1, 9.

Pediatrics: 10-14 days or until symptom-free for 7 days 2, 1, 3

Frontal, ethmoidal, or sphenoidal sinusitis: Consider longer duration (10-14 days) due to higher risk of complications 5, 2

When to Refer to a Specialist

Refer to otolaryngology or allergy/immunology for 2:

  • Symptoms refractory to two courses of appropriate antibiotics 2
  • Recurrent sinusitis (≥3 episodes per year) 2
  • Suspected complications: orbital cellulitis, meningitis, severe frontal/sphenoidal sinusitis 5, 2
  • Need for sinus aspiration/culture in immunocompromised patients 2

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for viral rhinosinusitis lasting <10 days unless severe symptoms are present 2, 3
  • Do not use plain amoxicillin as first-line therapy given high prevalence of β-lactamase-producing organisms 1, 3
  • Do not continue ineffective antibiotics beyond 3-5 days—failure to reassess and switch therapy leads to prolonged illness and complications 2, 1, 3
  • Do not reserve fluoroquinolones as routine first-line therapy—use only for treatment failures, severe disease, or documented penicillin allergy to prevent resistance 2, 1, 6
  • Do not use systemic corticosteroids without antibiotics when bacterial sinusitis is suspected, as this may suppress immune response and allow bacterial proliferation 2

References

Guideline

Antibiotic Recommendations for Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Bacterial Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Beginning antibiotics for acute rhinosinusitis and choosing the right treatment.

Clinical reviews in allergy & immunology, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.